C
리센스메디컬
394420KOSDAQ46.0 / 100
Reference Date: 2026-10-23
Financial Score20.5 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Plunged 25.6% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
License Medical develops innovative medical devices through the FDA De Novo process and specializes in regulatory evaluation for retinal and diagnostic medical devices. The company leverages cryogenic cooling technology and transdermal drug delivery systems to create advanced solutions for ophthalmic conditions such as macular degeneration and diabetic retinopathy.
Number of Employees
55people
Average Salary
54.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
10.69Industry Average 1.200.0Point
8.9x industry avg (risky)
ROE
—Industry Average 8.003.5Point
Debt Ratio
27.41Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 5.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
2.0 / 4
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (2%, downtrend)
Current 6,780Won52-week high 33,90052-week low 6,090
1-month return0.0Point
1m -25.58% (strong drop)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0